» Articles » PMID: 33989861

Adjunctive Homeopathic Treatment of Hospitalized COVID-19 Patients (COVIHOM): A Retrospective Case Series

Overview
Publisher Elsevier
Specialty General Medicine
Date 2021 May 14
PMID 33989861
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: and purpose. COVID-19 is a novel viral disease causing worldwide pandemia. The aim of this study was to describe the effect of adjunctive individualized homeopathic treatment delivered to hospitalized patients with confirmed symptomatic SARS-CoV-2 infection.

Patient Presentation: Thirteen patients with COVID-19 were admitted. Mean age was 73.4 ± 15.0 (SD) years. Twelve (92.3%) were speedily discharged without relevant sequelae after 14.4 ± 8.9 days. A single patient admitted in an advanced stage of septic disease died in hospital. A time-dependent improvement of relevant clinical symptoms was observed in the 12 surviving patients. Six (46.2%) were critically ill and treated in the intensive care unit (ICU). Mean stay at the ICU of the 5 surviving patients was 18.8 ± 6.8 days. In six patients (46.2%) gastrointestinal disorders accompanied COVID-19.

Conclusion: The observations suggest that adjunctive homeopathic treatment may be helpful to treat patients with confirmed COVID-19 even in high - risk patients especially since there is no conventional treatment of COVID-19 available at present.

Citing Articles

Integrative and complementary practices in Intensive Care Units: An integrative review.

de Melo Alves Silva L, de Farias L, de Lima V, Guerrero Soares S, Paiva F, de Assis L Heliyon. 2024; 10(22):e40333.

PMID: 39634435 PMC: 11616508. DOI: 10.1016/j.heliyon.2024.e40333.


Searching for the Genus Epidemicus in Chinese Patients: Findings from the Clificol COVID-19 Clinical Case Registry.

Tournier A, Fok Y, Haselen R, To A Homeopathy. 2022; 112(1):30-39.

PMID: 36183700 PMC: 9868965. DOI: 10.1055/s-0042-1750380.


Consumption of Herbal Supplements or Homeopathic Remedies to Prevent COVID-19 and Intention of Vaccination for COVID-19 in Latin America and the Caribbean.

Bendezu-Quispe G, Benites-Meza J, Urrunaga-Pastor D, Herrera-Anazco P, Uyen-Cateriano A, Rodriguez-Morales A Trop Med Infect Dis. 2022; 7(6).

PMID: 35736974 PMC: 9229216. DOI: 10.3390/tropicalmed7060095.


Efficacy of individualized homeopathy as an adjunct to standard of care of COVID-19: A randomized, single-blind, placebo-controlled study.

Nayak D, Gupta J, Chaudhary A, Singh K, Deshmukh A, Das D Complement Ther Clin Pract. 2022; 48:101602.

PMID: 35569230 PMC: 9080028. DOI: 10.1016/j.ctcp.2022.101602.

References
1.
Conde Diez S, Viejo Casas A, Garcia Rivero J, Lopez Caro J, Ortiz Portal F, Diaz Saez G . Impact of a homeopathic medication on upper respiratory tract infections in COPD patients: Results of an observational, prospective study (EPOXILO). Respir Med. 2019; 146:96-105. DOI: 10.1016/j.rmed.2018.11.011. View

2.
Lamba C, Gupta V, Haselen R, Rutten L, Mahajan N, Molla A . Evaluation of the Modified Naranjo Criteria for Assessing Causal Attribution of Clinical Outcome to Homeopathic Intervention as Presented in Case Reports. Homeopathy. 2020; 109(4):191-197. DOI: 10.1055/s-0040-1701251. View

3.
Frass M, Linkesch M, Banyai S, Resch G, Dielacher C, Lobl T . Adjunctive homeopathic treatment in patients with severe sepsis: a randomized, double-blind, placebo-controlled trial in an intensive care unit. Homeopathy. 2005; 94(2):75-80. DOI: 10.1016/j.homp.2005.01.002. View

4.
Corman V, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu D . Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020; 25(3). PMC: 6988269. DOI: 10.2807/1560-7917.ES.2020.25.3.2000045. View

5.
Rossi E . The Experience of an Italian Public Homeopathy Clinic during the COVID-19 Epidemic, March-May 2020. Homeopathy. 2020; 109(3):167-168. DOI: 10.1055/s-0040-1713618. View